2021-05-04 02:36:46,283 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Starting Heading Extraction | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json
2021-05-04 02:44:00,078 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Starting Heading Extraction | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json
2021-05-04 02:44:00,437 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Started Extracting Heading | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json
2021-05-04 02:44:00,679 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Qrd txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Matched :- 'True'
2021-05-04 02:44:00,685 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed As This The First Heading | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20001' | currParentHeadId :- 'nan' | prevParentHeadId :- ''
2021-05-04 02:44:00,722 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- '1.       NAME OF THE MEDICINAL PRODUCT' | Qrd txt :- '1. NAME OF THE MEDICINAL PRODUCT' | Matched :- 'True'
2021-05-04 02:44:00,731 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'
2021-05-04 02:44:00,735 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'
2021-05-04 02:44:01,231 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- '2.       QUALITATIVE AND QUANTITATIVE COMPOSITION' | Qrd txt :- '2. QUALITATIVE AND QUANTITATIVE COMPOSITION' | Matched :- 'True'
2021-05-04 02:44:01,240 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20004' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20003'
2021-05-04 02:44:01,576 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Each film‑coated tablet contains 150 mg of ivacaftor.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:44:01,681 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Excipient with known effect' | Qrd txt :- 'Excipient(s) with known effect' | Matched :- 'True'
2021-05-04 02:44:01,692 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20007' | currParentHeadId :- '20006.0' | prevParentHeadId :- '20004'
2021-05-04 02:44:01,702 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20007' | currParentHeadId :- '20006.0' | prevParentHeadId :- '20004'
2021-05-04 02:44:02,015 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Each film‑coated tablet contains 167.2 mg of lactose monohydrate.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:02,427 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- '3.       PHARMACEUTICAL FORM' | Qrd txt :- '3. PHARMACEUTICAL FORM' | Matched :- 'True'
2021-05-04 02:44:02,438 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'
2021-05-04 02:44:02,445 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'
2021-05-04 02:44:03,029 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Light blue, capsule‑shaped film‑coated tablets, printed with “V 150” in black ink on one side and plain on the other (16.5 mm x 8.4 mm in modified tablet shape).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:03,105 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- '4.       CLINICAL PARTICULARS' | Qrd txt :- '4. CLINICAL PARTICULARS' | Matched :- 'True'
2021-05-04 02:44:03,113 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20009' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20008'
2021-05-04 02:44:03,200 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- '4.1     Therapeutic indications' | Qrd txt :- '4.1 Therapeutic indications' | Matched :- 'True'
2021-05-04 02:44:03,208 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20010' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20009'
2021-05-04 02:44:03,666 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- '4.2     Posology and method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'True'
2021-05-04 02:44:03,676 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20011' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20010'
2021-05-04 02:44:03,728 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'
2021-05-04 02:44:03,730 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- 'Posology' | Matched :- 'True'
2021-05-04 02:44:03,750 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20012' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'
2021-05-04 02:44:04,684 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'The morning and evening dose should be taken approximately 12 hours apart with fat-containing food (see Method of administration).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:05,142 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Patients receiving ivacaftor in a combination regimen should not take more than one dose of either medicine at the same time.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:06,141 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Table 2: Dosing recommendations for concomitant use with moderate or strong CYP3A inhibitors' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:06,662 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Special populations' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:44:08,501 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'No dose adjustment is necessary for ivacaftor as monotherapy or in a combination regimen in patients with mild hepatic impairment (Child‑Pugh Class A). ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:08,836 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'For patients with moderate hepatic impairment (Child‑Pugh Class B) the dose of ivacaftor as monotherapy should be reduced to 150 mg once daily. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:09,091 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'For patients with severe hepatic impairment (Child-Pugh Class C), the dose of ivacaftor as monotherapy should be reduced to 150 mg every other day or less frequently. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:09,386 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'For use as an evening dose in a combination regimen with tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexacaftor see Table 3 for dosing regimen recommendations. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:09,740 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Table 3: Recommendations for patients with moderate or severe hepatic impairment ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:09,764 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Table 3: Recommendations for patients with moderate or severe hepatic impairment ' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:44:10,470 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:44:10,491 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20011'
2021-05-04 02:44:10,829 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'The safety and efficacy of ivacaftor monotherapy in children aged less than 4 months have not been established. No data are available.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:11,135 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'An appropriate dose for children under 6 years of age and weighing less than 25 kg cannot be achieved with ivacaftor tablets.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:11,570 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'
2021-05-04 02:44:11,580 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Method of administration' | Qrd txt :- 'Method of administration ' | Matched :- 'True'
2021-05-04 02:44:11,604 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20014' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'
2021-05-04 02:44:12,695 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Food or drink containing grapefruit should be avoided during treatment (see section 4.5).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:12,857 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- '4.3       Contraindications' | Qrd txt :- '4.3 Contraindications' | Matched :- 'True'
2021-05-04 02:44:12,871 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20016' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20011'
2021-05-04 02:44:13,068 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:13,273 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- '4.4       Special warnings and precautions for use' | Qrd txt :- '4.4 Special warnings and precautions for use' | Matched :- 'True'
2021-05-04 02:44:13,288 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20017' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20016'
2021-05-04 02:44:13,751 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Less evidence of a positive effect of ivacaftor has been shown for patients with an R117H‑7T mutation associated with less severe disease in study 6 (see section 5.1). ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:16,232 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Interactions with medicinal products' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:16,245 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Interactions with medicinal products' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:44:17,019 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:44:17,030 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20017'
2021-05-04 02:44:17,067 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:44:17,086 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20019' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20017'
2021-05-04 02:44:17,682 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Kalydeco contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose‑galactose malabsorption should not take this medicine.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:18,378 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- '4.5          Interaction with other medicinal products and other forms of interaction' | Qrd txt :- '4.5 Interaction with other medicinal products and other forms of interaction' | Matched :- 'True'
2021-05-04 02:44:18,394 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20020' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20017'
2021-05-04 02:44:18,906 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Medicinal products affecting the pharmacokinetics of ivacaftor, tezacaftor and/or elexacaftor' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:18,943 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Medicinal products affecting the pharmacokinetics of ivacaftor, tezacaftor and/or elexacaftor' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:44:20,123 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Potential for ivacaftor to interact with transporters' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:20,816 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Medicinal products affected by ivacaftor, tezacaftor and/or elexacaftor' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:22,795 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:44:22,809 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20020'
2021-05-04 02:44:22,853 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:44:22,867 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20019' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20020'
2021-05-04 02:44:22,880 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:44:22,902 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20021' | currParentHeadId :- '20020.0' | prevParentHeadId :- '20020'
2021-05-04 02:44:23,212 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Interaction studies have only been performed in adults.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:44:23,592 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- '4.6    Fertility, pregnancy and lactation' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'True'
2021-05-04 02:44:23,623 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20022' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20020'
2021-05-04 02:44:23,858 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Pregnancy' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'False'
2021-05-04 02:44:23,862 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Pregnancy' | Qrd txt :- 'Pregnancy' | Matched :- 'True'
2021-05-04 02:44:23,909 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20023' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'
2021-05-04 02:44:24,165 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Match Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | Doc txt :- 'Breast‑feeding' | Qrd txt :- 'Breast-feeding' | Matched :- 'True'
2021-05-04 02:44:24,191 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Validation Passed | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json | currHeadId :- '20024' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'
2021-05-04 02:44:43,843 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Starting Heading Extraction | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json
2021-05-04 02:44:43,843 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Starting Heading Extraction | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json
2021-05-04 02:44:44,230 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Started Extracting Heading | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json
2021-05-04 02:44:44,230 : Heading Extraction Kalydeco II-86-PI-clean_SmPC.json : Started Extracting Heading | CAP |  en | 0 | Kalydeco II-86-PI-clean_SmPC.json
2021-05-04 02:47:20,635 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Starting Heading Extraction | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json
2021-05-04 02:47:21,014 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Started Extracting Heading | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json
2021-05-04 02:47:21,287 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Qrd txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Matched :- 'True'
2021-05-04 02:47:21,293 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed As This The First Heading | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20001' | currParentHeadId :- 'nan' | prevParentHeadId :- ''
2021-05-04 02:47:21,335 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '1.       NAME OF THE MEDICINAL PRODUCT' | Qrd txt :- '1. NAME OF THE MEDICINAL PRODUCT' | Matched :- 'True'
2021-05-04 02:47:21,346 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'
2021-05-04 02:47:21,351 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'
2021-05-04 02:47:21,817 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '2.       QUALITATIVE AND QUANTITATIVE COMPOSITION' | Qrd txt :- '2. QUALITATIVE AND QUANTITATIVE COMPOSITION' | Matched :- 'True'
2021-05-04 02:47:21,828 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20004' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20003'
2021-05-04 02:47:22,526 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Each cartridge contains 3 mL of solution for injection, equivalent to 300 units. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:23,339 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '3.       PHARMACEUTICAL FORM' | Qrd txt :- '3. PHARMACEUTICAL FORM' | Matched :- 'True'
2021-05-04 02:47:23,351 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'
2021-05-04 02:47:23,356 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'
2021-05-04 02:47:24,130 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.       CLINICAL PARTICULARS' | Qrd txt :- '4. CLINICAL PARTICULARS' | Matched :- 'True'
2021-05-04 02:47:24,142 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20009' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20008'
2021-05-04 02:47:24,238 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.1     Therapeutic indications' | Qrd txt :- '4.1 Therapeutic indications' | Matched :- 'True'
2021-05-04 02:47:24,247 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20010' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20009'
2021-05-04 02:47:24,498 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:24,542 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:47:24,767 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.2     Posology and method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'True'
2021-05-04 02:47:24,784 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20011' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20010'
2021-05-04 02:47:24,864 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'
2021-05-04 02:47:24,866 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- 'Posology' | Matched :- 'True'
2021-05-04 02:47:24,902 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20012' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'
2021-05-04 02:47:25,179 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR contains insulin glargine, an insulin analogue and has a prolonged duration of action. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:26,490 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Special populations' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:47:27,396 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In the elderly, progressive deterioration of renal function may lead to a steady decrease in insulin requirements.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:28,111 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:28,979 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In patients with hepatic impairment, insulin requirements may be diminished due to reduced capacity for gluconeogenesis and reduced insulin metabolism.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:29,077 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:47:29,097 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20011'
2021-05-04 02:47:30,281 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The safety and efficacy of insulin glargine have not been established No data are available. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:30,306 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The safety and efficacy of insulin glargine have not been established No data are available. ' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:47:32,011 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'During the first weeks the reduction should, at least partially, be compensated by an increase in mealtime insulin, after this period the regimen should be adjusted individually. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:32,234 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Close metabolic monitoring is recommended during the switch and in the initial weeks thereafter. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:32,667 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Patients with high insulin doses because of antibodies to human insulin may experience an improved insulin response with ABASAGLAR.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:32,809 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'
2021-05-04 02:47:32,818 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Method of administration' | Qrd txt :- 'Method of administration ' | Matched :- 'True'
2021-05-04 02:47:32,842 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20014' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'
2021-05-04 02:47:33,897 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'There are no clinically relevant differences in serum insulin or glucose levels after abdominal, deltoid or thigh administration of insulin glargine. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:34,110 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Injection sites should always be rotated within the same region in order to reduce the risk of lipodystrophy and cutaneous amyloidosis (see section 4.4 and 4.8).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:34,340 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR must not be mixed with any other insulin or diluted. Mixing or diluting can change its time/action profile and mixing can cause precipitation. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:34,860 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.3     Contraindications' | Qrd txt :- '4.3 Contraindications' | Matched :- 'True'
2021-05-04 02:47:34,874 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20016' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20011'
2021-05-04 02:47:35,096 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:35,318 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.4     Special warnings and precautions for use' | Qrd txt :- '4.4 Special warnings and precautions for use' | Matched :- 'True'
2021-05-04 02:47:35,329 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20017' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20016'
2021-05-04 02:47:35,443 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Traceability' | Qrd txt :- 'Traceability' | Matched :- 'True'
2021-05-04 02:47:35,463 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20018' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20017'
2021-05-04 02:47:35,724 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:36,399 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR is not the insulin of choice for the treatment of diabetic ketoacidosis. Instead, regular insulin administered intravenously is recommended in such cases. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:36,841 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Insulin requirements and dose adjustments' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:38,654 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        after transfer from animal insulin to human insulin,' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:38,666 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        after transfer from animal insulin to human insulin,' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:47:39,855 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        suffering from a psychiatric illness,' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:47:40,225 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        receiving concurrent treatment with certain other medicinal products (see section 4.5).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:40,588 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Such situations may result in severe hypoglycaemia (and possibly loss of consciousness) prior to the patient's awareness of hypoglycaemia.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:40,835 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The prolonged effect of subcutaneous insulin glargine may delay recovery from hypoglycaemia.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:40,881 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The prolonged effect of subcutaneous insulin glargine may delay recovery from hypoglycaemia.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:47:41,170 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'If normal or decreased values for glycated haemoglobin are noted, the possibility of recurrent, unrecognised (especially nocturnal) episodes of hypoglycaemia must be considered. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:42,360 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        unaccustomed, increased or prolonged physical activity,' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:42,375 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        unaccustomed, increased or prolonged physical activity,' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:47:44,062 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        certain uncompensated endocrine disorders, (e.g. in hypothyroidism and in anterior pituitary or adrenocortical insufficiency),' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:44,323 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        concomitant treatment with certain other medicinal products.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:47,240 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e., essentially “sodium‑free”.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:47,462 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.5     Interaction with other medicinal products and other forms of interaction' | Qrd txt :- '4.5 Interaction with other medicinal products and other forms of interaction' | Matched :- 'True'
2021-05-04 02:47:47,472 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20020' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20017'
2021-05-04 02:47:47,738 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:48,374 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.6     Fertility, pregnancy and lactation' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'True'
2021-05-04 02:47:48,385 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20022' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20020'
2021-05-04 02:47:48,489 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Pregnancy' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'False'
2021-05-04 02:47:48,491 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Pregnancy' | Qrd txt :- 'Pregnancy' | Matched :- 'True'
2021-05-04 02:47:48,511 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20023' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'
2021-05-04 02:47:48,822 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Animal data do not indicate reproductive toxicity. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:49,142 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The use of ABASAGLAR may be considered during pregnancy, if clinically needed. ' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:47:49,306 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Breast-feeding' | Qrd txt :- 'Breast-feeding' | Matched :- 'True'
2021-05-04 02:47:49,324 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20024' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'
2021-05-04 02:47:49,664 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Breast-feeding women may require adjustments in insulin dose and diet. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:49,832 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Fertility' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'False'
2021-05-04 02:47:49,846 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Fertility' | Qrd txt :- 'Fertility' | Matched :- 'True'
2021-05-04 02:47:49,872 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20025' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'
2021-05-04 02:47:50,203 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Animal studies do not indicate direct harmful effects with respect to fertility.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:50,475 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.7     Effects on ability to drive and use machines' | Qrd txt :- '4.7 Effects on ability to drive and use machines' | Matched :- 'True'
2021-05-04 02:47:50,491 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20026' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20022'
2021-05-04 02:47:50,708 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.8     Undesirable effects' | Qrd txt :- '4.8 Undesirable effects' | Matched :- 'True'
2021-05-04 02:47:50,721 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20027' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20026'
2021-05-04 02:47:51,388 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Hypoglycaemia (very common), in general the most frequent adverse reaction of insulin therapy, may occur if the insulin dose is too high in relation to the insulin requirement (see section 4.4).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:51,813 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Tabulated list of adverse reactions' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:47:52,097 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:52,600 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Description of selected adverse reactions' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:53,030 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Metabolism and nutrition disorders' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:53,043 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Metabolism and nutrition disorders' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:47:54,104 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'A marked change in glycaemic control may cause temporary visual impairment, due to temporary alteration in the turgidity and refractive index of the lens.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:54,522 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Skin and subcutaneous tissue disorders' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:47:55,141 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'General disorders and administration site conditions' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:55,511 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Injection site reactions include redness, pain, itching, hives, swelling, or inflammation. Most minor reactions to insulins at the injection site usually resolve in a few days to a few weeks. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:55,896 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Rarely, insulin may cause sodium retention and oedema particularly if previously poor metabolic control is improved by intensified insulin therapy.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:55,992 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:47:56,004 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20027'
2021-05-04 02:47:56,041 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:47:56,052 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20019' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20027'
2021-05-04 02:47:56,065 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:47:56,084 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20021' | currParentHeadId :- '20020.0' | prevParentHeadId :- '20027'
2021-05-04 02:47:56,168 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:47:56,188 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20028' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20027'
2021-05-04 02:47:56,530 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Reporting of suspected adverse reactions' | Qrd txt :- 'Reporting of suspected adverse reactions' | Matched :- 'True'
2021-05-04 02:47:56,557 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20029' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20027'
2021-05-04 02:47:56,774 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.9     Overdose' | Qrd txt :- '4.9 Overdose' | Matched :- 'True'
2021-05-04 02:47:56,792 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20030' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20027'
2021-05-04 02:47:57,369 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Insulin overdose may lead to severe and sometimes long-term and life-threatening hypoglycaemia. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:58,081 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Mild episodes of hypoglycaemia can usually be treated with oral carbohydrates. Adjustments in dose of the medicinal product, meal patterns, or physical activity may be needed. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:58,312 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '5.       PHARMACOLOGICAL PROPERTIES' | Qrd txt :- '5. PHARMACOLOGICAL PROPERTIES' | Matched :- 'True'
2021-05-04 02:47:58,326 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20032' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20030'
2021-05-04 02:47:58,584 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '5.1     Pharmacodynamic properties' | Qrd txt :- '5.1 Pharmacodynamic properties' | Matched :- 'True'
2021-05-04 02:47:58,598 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20033' | currParentHeadId :- '20032.0' | prevParentHeadId :- '20032'
2021-05-04 02:47:58,932 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, long-acting. ATC Code: A10AE04.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:59,330 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR is a biosimilar medicinal product. Detailed information is available on the website of the European Medicines Agency http://www.ema.europa.eu.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:47:59,575 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Mechanism of action' | Qrd txt :- 'Mechanism of action' | Matched :- 'True'
2021-05-04 02:47:59,597 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20034' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'
2021-05-04 02:47:59,898 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Insulin glargine is metabolised into 2 active metabolites M1 and M2 (see section 5.2).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:00,312 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Insulin receptor binding' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:00,590 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In vitro studies indicate that the affinity of insulin glargine and its metabolites M1 and M2 for the human insulin receptor is similar to the one of human insulin.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:00,827 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Pharmacodynamic effects' | Qrd txt :- 'Pharmacodynamic effects' | Matched :- 'True'
2021-05-04 02:48:00,845 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20035' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'
2021-05-04 02:48:01,888 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '* Determined as amount of glucose infused to maintain constant plasma glucose levels (hourly mean values)' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:01,922 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '* Determined as amount of glucose infused to maintain constant plasma glucose levels (hourly mean values)' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:02,395 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Clinical safety and efficacy' | Qrd txt :- 'Clinical efficacy and safety' | Matched :- 'False'
2021-05-04 02:48:02,802 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In clinical studies, antibodies that cross-react with human insulin and insulin glargine were observed with the same frequency in both NPH-insulin and insulin glargine treatment groups.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:03,132 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Secondary endpoints included all-cause mortality and a composite microvascular outcome.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:03,168 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Secondary endpoints included all-cause mortality and a composite microvascular outcome.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:03,483 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'At the last on-treatment visit, there was a mean increase in body weight from baseline of 1.4 kg in the insulin glargine group and a mean decrease of 0.8 kg in the standard care group.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:03,574 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:03,585 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20033'
2021-05-04 02:48:03,625 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:03,638 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20019' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20033'
2021-05-04 02:48:03,650 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:03,660 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20021' | currParentHeadId :- '20020.0' | prevParentHeadId :- '20033'
2021-05-04 02:48:03,695 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:03,707 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20028' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20033'
2021-05-04 02:48:03,726 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:03,738 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20031' | currParentHeadId :- '20030.0' | prevParentHeadId :- '20033'
2021-05-04 02:48:03,768 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:03,788 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20037' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'
2021-05-04 02:48:04,027 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '5.2     Pharmacokinetic properties' | Qrd txt :- '5.1 Pharmacodynamic properties' | Matched :- 'False'
2021-05-04 02:48:04,057 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '5.2     Pharmacokinetic properties' | Qrd txt :- '5.2 Pharmacokinetic properties' | Matched :- 'True'
2021-05-04 02:48:04,070 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20038' | currParentHeadId :- '20032.0' | prevParentHeadId :- '20033'
2021-05-04 02:48:04,247 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Absorption' | Qrd txt :- 'Absorption' | Matched :- 'True'
2021-05-04 02:48:04,267 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20039' | currParentHeadId :- '20038.0' | prevParentHeadId :- '20038'
2021-05-04 02:48:04,487 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Insulin glargine injected once daily will reach steady state levels in 2-4 days after the first dose. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:04,803 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Biotransformation' | Qrd txt :- 'Biotransformation' | Matched :- 'True'
2021-05-04 02:48:04,829 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20041' | currParentHeadId :- '20038.0' | prevParentHeadId :- '20038'
2021-05-04 02:48:05,051 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Elimination' | Qrd txt :- 'Elimination' | Matched :- 'True'
2021-05-04 02:48:05,076 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20042' | currParentHeadId :- '20038.0' | prevParentHeadId :- '20038'
2021-05-04 02:48:05,332 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'When given intravenously the elimination half-life of insulin glargine and human insulin were comparable. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:05,712 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Special populations' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:06,008 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In clinical studies, subgroup analyses based on age and gender did not indicate any difference in safety and efficacy in insulin glargine-treated patients compared to the entire study population.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:06,101 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:06,114 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20038'
2021-05-04 02:48:06,151 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:06,162 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20019' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20038'
2021-05-04 02:48:06,175 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:06,186 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20021' | currParentHeadId :- '20020.0' | prevParentHeadId :- '20038'
2021-05-04 02:48:06,221 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:06,233 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20028' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20038'
2021-05-04 02:48:06,252 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:06,265 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20031' | currParentHeadId :- '20030.0' | prevParentHeadId :- '20038'
2021-05-04 02:48:06,295 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:06,308 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20037' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20038'
2021-05-04 02:48:06,418 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:06,432 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Use in the paediatric population' | Matched :- 'False'
2021-05-04 02:48:06,769 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '5.3     Preclinical safety data' | Qrd txt :- '5.3 Preclinical safety data' | Matched :- 'True'
2021-05-04 02:48:06,782 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20045' | currParentHeadId :- '20032.0' | prevParentHeadId :- '20038'
2021-05-04 02:48:07,061 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:07,325 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.       PHARMACEUTICAL PARTICULARS' | Qrd txt :- '6. PHARMACEUTICAL PARTICULARS' | Matched :- 'True'
2021-05-04 02:48:07,337 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20047' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20045'
2021-05-04 02:48:07,713 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.1     List of excipients' | Qrd txt :- '6.1 List of excipients' | Matched :- 'True'
2021-05-04 02:48:07,723 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20048' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20047'
2021-05-04 02:48:09,925 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.2     Incompatibilities' | Qrd txt :- '6.2 Incompatibilities' | Matched :- 'True'
2021-05-04 02:48:09,936 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20049' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20048'
2021-05-04 02:48:10,165 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'This medicinal product must not be mixed with other medicinal products. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:10,181 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'This medicinal product must not be mixed with other medicinal products. ' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:10,473 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.3     Shelf life' | Qrd txt :- '6.3 Shelf life' | Matched :- 'True'
2021-05-04 02:48:10,490 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20050' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20049'
2021-05-04 02:48:11,256 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The medicinal product may be stored for a maximum of 28 days up to 30°C and away from direct heat or direct light. Pens in use must not be stored in the refrigerator. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:11,434 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The pen cap must be put back on the pen after each injection in order to protect from light.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:11,855 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.4     Special precautions for storage' | Qrd txt :- '6.4 Special precautions for storage' | Matched :- 'True'
2021-05-04 02:48:11,865 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20051' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20050'
2021-05-04 02:48:13,783 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'For storage conditions after first opening of this medicinal product, see section 6.3.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:14,243 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.5     Nature and contents of container' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'True'
2021-05-04 02:48:14,254 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20052' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20051'
2021-05-04 02:48:14,516 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '3 mL solution in a cartridge (type 1 colourless glass) with a plunger (halobutyl rubber) and a disc seal (laminate of polyisoprene and halobutyl rubber) with aluminium seal.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:15,079 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.6     Special precautions for disposal and other handling' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:15,089 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.6     Special precautions for disposal and other handling' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'True'
2021-05-04 02:48:15,100 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20053' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20052'
2021-05-04 02:48:15,409 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR must not be mixed with any other insulin or medicinal products or diluted. Mixing or diluting can change its time/action profile and mixing can cause precipitation.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:15,887 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The ABASAGLAR cartridges are to be used only in conjunction with a Lilly reusable insulin pen (see section 4.4). ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:16,531 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The instructions for using the pen must be followed carefully for loading the cartridge, attaching the needle, and administering the insulin injection. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:16,821 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'If the insulin pen is damaged or not working properly (due to mechanical defects) it has to be discarded, and a new insulin pen has to be used. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:17,323 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'To prevent the possible transmission of disease, each pen must be used by one patient only. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:17,368 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'To prevent the possible transmission of disease, each pen must be used by one patient only. ' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:17,948 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '7.       MARKETING AUTHORISATION HOLDER' | Qrd txt :- '7. MARKETING AUTHORISATION HOLDER' | Matched :- 'True'
2021-05-04 02:48:17,959 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20055' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20053'
2021-05-04 02:48:18,755 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '8.       MARKETING AUTHORISATION NUMBER(S)' | Qrd txt :- '7. MARKETING AUTHORISATION HOLDER' | Matched :- 'False'
2021-05-04 02:48:18,756 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '8.       MARKETING AUTHORISATION NUMBER(S)' | Qrd txt :- '8. MARKETING AUTHORISATION NUMBER(S)' | Matched :- 'True'
2021-05-04 02:48:18,767 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20056' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20055'
2021-05-04 02:48:19,591 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION' | Qrd txt :- '9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION' | Matched :- 'True'
2021-05-04 02:48:19,610 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20057' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20056'
2021-05-04 02:48:20,739 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '10.     DATE OF REVISION OF THE TEXT' | Qrd txt :- '10. DATE OF REVISION OF THE TEXT' | Matched :- 'True'
2021-05-04 02:48:20,749 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20058' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20057'
2021-05-04 02:48:21,027 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu  1.       NAME OF THE MEDICINAL PRODUCT' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:21,658 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR 100 units/mL Tempo Pen solution for injection in a pre-filled pen' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:21,765 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '2.       QUALITATIVE AND QUANTITATIVE COMPOSITION' | Qrd txt :- '2. QUALITATIVE AND QUANTITATIVE COMPOSITION' | Matched :- 'True'
2021-05-04 02:48:21,775 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20004' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20058'
2021-05-04 02:48:21,804 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '2.       qualitative and quantitative composition' | Qrd txt :- '2.2 qualitative and quantitative composition' | Matched :- 'True'
2021-05-04 02:48:21,805 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '2.       QUALITATIVE AND QUANTITATIVE COMPOSITION' | Qrd txt :- '2.2 Qualitative and quantitative composition' | Matched :- 'True'
2021-05-04 02:48:21,818 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Wrong Heading Found | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20006' | currParentHeadId :- '20004.0' | prevParentHeadId :- '20058'
2021-05-04 02:48:22,177 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : End Of Sub Section | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json
2021-05-04 02:48:22,237 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '2.       QUALITATIVE AND QUANTITATIVE COMPOSITION' | Qrd txt :- '2. QUALITATIVE AND QUANTITATIVE COMPOSITION' | Matched :- 'True'
2021-05-04 02:48:22,244 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed As This The First Heading | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20004' | currParentHeadId :- '20001.0' | prevParentHeadId :- ''
2021-05-04 02:48:22,906 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Each pen contains 3 mL of solution for injection, equivalent to 300 units. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:23,778 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '3.       PHARMACEUTICAL FORM' | Qrd txt :- '3. PHARMACEUTICAL FORM' | Matched :- 'True'
2021-05-04 02:48:23,791 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'
2021-05-04 02:48:23,797 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'
2021-05-04 02:48:24,570 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.       CLINICAL PARTICULARS' | Qrd txt :- '4. CLINICAL PARTICULARS' | Matched :- 'True'
2021-05-04 02:48:24,579 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20009' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20008'
2021-05-04 02:48:24,672 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.1     Therapeutic indications' | Qrd txt :- '4.1 Therapeutic indications' | Matched :- 'True'
2021-05-04 02:48:24,685 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20010' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20009'
2021-05-04 02:48:24,932 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:24,975 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:25,204 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.2     Posology and method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'True'
2021-05-04 02:48:25,220 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20011' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20010'
2021-05-04 02:48:25,299 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'
2021-05-04 02:48:25,303 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- 'Posology' | Matched :- 'True'
2021-05-04 02:48:25,336 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20012' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'
2021-05-04 02:48:25,566 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR contains insulin glargine, an insulin analogue and has a prolonged duration of action. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:26,470 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Special populations' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:27,195 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In the elderly, progressive deterioration of renal function may lead to a steady decrease in insulin requirements.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:27,861 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:28,801 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In patients with hepatic impairment, insulin requirements may be diminished due to reduced capacity for gluconeogenesis and reduced insulin metabolism.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:28,903 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:28,923 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20011'
2021-05-04 02:48:29,975 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The safety and efficacy of insulin glargine have not been established. No data are available. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:29,994 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The safety and efficacy of insulin glargine have not been established. No data are available. ' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:31,407 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'During the first weeks the reduction should, at least partially, be compensated by an increase in mealtime insulin, after this period the regimen should be adjusted individually. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:31,683 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Close metabolic monitoring is recommended during the switch and in the initial weeks thereafter. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:32,070 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Patients with high insulin doses because of antibodies to human insulin may experience an improved insulin response with ABASAGLAR.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:32,166 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'
2021-05-04 02:48:32,175 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Method of administration' | Qrd txt :- 'Method of administration ' | Matched :- 'True'
2021-05-04 02:48:32,198 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20014' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'
2021-05-04 02:48:34,210 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'There are no clinically relevant differences in serum insulin or glucose levels after abdominal, deltoid or thigh administration of insulin glargine. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:34,507 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Injection sites should always be rotated within the same region in order to reduce the risk of lipodystrophy and cutaneous amyloidosis (see section 4.4 and 4.8).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:34,781 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR must not be mixed with any other insulin or diluted. Mixing or diluting can change its time/action profile and mixing can cause precipitation. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:35,473 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Before using ABASAGLAR solution for injection in pre‑filled pen, the instructions for use included in the package leaflet must be read carefully (see section 6.6).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:36,154 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The Tempo Pen delivers 1 – 80 units in steps of 1 unit in a single injection. The needed dose is dialled in units. The number of units is shown in the dose window of the pen.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:36,326 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The Tempo Pen can be used with the optional transfer module Tempo Smart Button (see section 6.6).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:36,518 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.3     Contraindications' | Qrd txt :- '4.3 Contraindications' | Matched :- 'True'
2021-05-04 02:48:36,530 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20016' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20011'
2021-05-04 02:48:36,724 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:36,970 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.4     Special warnings and precautions for use' | Qrd txt :- '4.4 Special warnings and precautions for use' | Matched :- 'True'
2021-05-04 02:48:36,986 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20017' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20016'
2021-05-04 02:48:37,104 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Traceability' | Qrd txt :- 'Traceability' | Matched :- 'True'
2021-05-04 02:48:37,126 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20018' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20017'
2021-05-04 02:48:37,441 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In order to improve the traceability of biological medicinal products, the name and the batch number of the administered medicinal product should be clearly recorded.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:39,324 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR is not the insulin of choice for the treatment of diabetic ketoacidosis. Instead, regular insulin administered intravenously is recommended in such cases. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:40,122 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Insulin requirements and dose adjustments' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:42,347 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        after transfer from animal insulin to human insulin,' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:42,359 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        after transfer from animal insulin to human insulin,' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:43,450 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        suffering from a psychiatric illness,' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:43,803 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        receiving concurrent treatment with certain other medicinal products (see section 4.5).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:44,150 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Such situations may result in severe hypoglycaemia (and possibly loss of consciousness) prior to the patient's awareness of hypoglycaemia.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:44,397 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The prolonged effect of subcutaneous insulin glargine may delay recovery from hypoglycaemia.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:44,440 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The prolonged effect of subcutaneous insulin glargine may delay recovery from hypoglycaemia.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:44,716 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'If normal or decreased values for glycated haemoglobin are noted, the possibility of recurrent, unrecognised (especially nocturnal) episodes of hypoglycaemia must be considered. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:45,867 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        unaccustomed, increased or prolonged physical activity,' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:45,882 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        unaccustomed, increased or prolonged physical activity,' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:47,611 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        certain uncompensated endocrine disorders, (e.g. in hypothyroidism and in anterior pituitary or adrenocortical insufficiency),' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:47,872 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '-        concomitant treatment with certain other medicinal products.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:50,665 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e., essentially “sodium‑free”.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:50,898 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.5     Interaction with other medicinal products and other forms of interaction' | Qrd txt :- '4.5 Interaction with other medicinal products and other forms of interaction' | Matched :- 'True'
2021-05-04 02:48:50,914 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20020' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20017'
2021-05-04 02:48:51,182 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:51,817 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.6     Fertility, pregnancy and lactation' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'True'
2021-05-04 02:48:51,828 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20022' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20020'
2021-05-04 02:48:51,935 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Pregnancy' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'False'
2021-05-04 02:48:51,936 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Pregnancy' | Qrd txt :- 'Pregnancy' | Matched :- 'True'
2021-05-04 02:48:51,954 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20023' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'
2021-05-04 02:48:52,268 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Animal data do not indicate reproductive toxicity. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:52,581 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The use of ABASAGLAR may be considered during pregnancy, if clinically needed.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:52,740 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Breast-feeding' | Qrd txt :- 'Breast-feeding' | Matched :- 'True'
2021-05-04 02:48:52,757 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20024' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'
2021-05-04 02:48:53,108 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Breast-feeding women may require adjustments in insulin dose and diet. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:53,261 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Fertility' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'False'
2021-05-04 02:48:53,270 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Fertility' | Qrd txt :- 'Fertility' | Matched :- 'True'
2021-05-04 02:48:53,291 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20025' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'
2021-05-04 02:48:53,559 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Animal studies do not indicate direct harmful effects with respect to fertility.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:53,774 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.7     Effects on ability to drive and use machines' | Qrd txt :- '4.7 Effects on ability to drive and use machines' | Matched :- 'True'
2021-05-04 02:48:53,785 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20026' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20022'
2021-05-04 02:48:53,965 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.8     Undesirable effects' | Qrd txt :- '4.8 Undesirable effects' | Matched :- 'True'
2021-05-04 02:48:53,978 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20027' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20026'
2021-05-04 02:48:54,600 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Hypoglycaemia (very common), in general the most frequent adverse reaction of insulin therapy, may occur if the insulin dose is too high in relation to the insulin requirement (see section 4.4).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:55,023 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Tabulated list of adverse reactions' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:55,302 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:55,806 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Description of selected adverse reactions' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:56,228 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Metabolism and nutrition disorders' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:56,240 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Metabolism and nutrition disorders' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:57,305 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'A marked change in glycaemic control may cause temporary visual impairment, due to temporary alteration in the turgidity and refractive index of the lens.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:57,768 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Skin and subcutaneous tissue disorders' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:48:58,411 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'General disorders and administration site conditions' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:58,812 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Injection site reactions include redness, pain, itching, hives, swelling, or inflammation. Most minor reactions to insulins at the injection site usually resolve in a few days to a few weeks. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:59,247 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Rarely, insulin may cause sodium retention and oedema particularly if previously poor metabolic control is improved by intensified insulin therapy.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:48:59,348 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:59,360 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20027'
2021-05-04 02:48:59,400 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:59,412 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20019' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20027'
2021-05-04 02:48:59,424 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:59,437 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20021' | currParentHeadId :- '20020.0' | prevParentHeadId :- '20027'
2021-05-04 02:48:59,473 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:48:59,491 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20028' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20027'
2021-05-04 02:48:59,758 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Reporting of suspected adverse reactions' | Qrd txt :- 'Reporting of suspected adverse reactions' | Matched :- 'True'
2021-05-04 02:48:59,777 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20029' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20027'
2021-05-04 02:49:00,080 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.9     Overdose' | Qrd txt :- '4.9 Overdose' | Matched :- 'True'
2021-05-04 02:49:00,099 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20030' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20027'
2021-05-04 02:49:00,692 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Insulin overdose may lead to severe and sometimes long-term and life-threatening hypoglycaemia. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:01,292 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Mild episodes of hypoglycaemia can usually be treated with oral carbohydrates. Adjustments in dose of the medicinal product, meal patterns, or physical activity may be needed. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:01,476 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '5.       PHARMACOLOGICAL PROPERTIES' | Qrd txt :- '5. PHARMACOLOGICAL PROPERTIES' | Matched :- 'True'
2021-05-04 02:49:01,488 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20032' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20030'
2021-05-04 02:49:01,710 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '5.1     Pharmacodynamic properties' | Qrd txt :- '5.1 Pharmacodynamic properties' | Matched :- 'True'
2021-05-04 02:49:01,719 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20033' | currParentHeadId :- '20032.0' | prevParentHeadId :- '20032'
2021-05-04 02:49:02,016 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Pharmacotherapeutic group: Drugs used in diabetes, insulins and analogues for injection, long-acting. ATC Code: A10AE04.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:02,336 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR is a biosimilar medicinal product. Detailed information is available on the website of the European Medicines Agency http://www.ema.europa.eu.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:02,531 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Mechanism of action' | Qrd txt :- 'Mechanism of action' | Matched :- 'True'
2021-05-04 02:49:02,549 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20034' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'
2021-05-04 02:49:02,809 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Insulin glargine is metabolised into 2 active metabolites M1 and M2 (see section 5.2).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:03,193 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Insulin receptor binding' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:03,459 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In vitro studies indicate that the affinity of insulin glargine and its metabolites M1 and M2 for the human insulin receptor is similar to the one of human insulin.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:03,666 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Pharmacodynamic effects' | Qrd txt :- 'Pharmacodynamic effects' | Matched :- 'True'
2021-05-04 02:49:03,684 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20035' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'
2021-05-04 02:49:04,691 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '* Determined as amount of glucose infused to maintain constant plasma glucose levels (hourly mean values)' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:04,724 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '* Determined as amount of glucose infused to maintain constant plasma glucose levels (hourly mean values)' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:05,183 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Clinical safety and efficacy' | Qrd txt :- 'Clinical efficacy and safety' | Matched :- 'False'
2021-05-04 02:49:05,670 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In clinical studies, antibodies that cross-react with human insulin and insulin glargine were observed with the same frequency in both NPH-insulin and insulin glargine treatment groups.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:06,066 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Secondary endpoints included all-cause mortality and a composite microvascular outcome.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:06,103 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Secondary endpoints included all-cause mortality and a composite microvascular outcome.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:06,438 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'At the last on-treatment visit, there was a mean increase in body weight from baseline of 1.4 kg in the insulin glargine group and a mean decrease of 0.8 kg in the standard care group.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:06,535 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:06,547 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20033'
2021-05-04 02:49:06,591 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:06,604 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20019' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20033'
2021-05-04 02:49:06,615 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:06,628 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20021' | currParentHeadId :- '20020.0' | prevParentHeadId :- '20033'
2021-05-04 02:49:06,668 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:06,680 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20028' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20033'
2021-05-04 02:49:06,701 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:06,712 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20031' | currParentHeadId :- '20030.0' | prevParentHeadId :- '20033'
2021-05-04 02:49:06,744 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:06,767 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20037' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'
2021-05-04 02:49:07,010 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '5.2     Pharmacokinetic properties' | Qrd txt :- '5.1 Pharmacodynamic properties' | Matched :- 'False'
2021-05-04 02:49:07,041 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '5.2     Pharmacokinetic properties' | Qrd txt :- '5.2 Pharmacokinetic properties' | Matched :- 'True'
2021-05-04 02:49:07,056 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20038' | currParentHeadId :- '20032.0' | prevParentHeadId :- '20033'
2021-05-04 02:49:07,226 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Absorption' | Qrd txt :- 'Absorption' | Matched :- 'True'
2021-05-04 02:49:07,246 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20039' | currParentHeadId :- '20038.0' | prevParentHeadId :- '20038'
2021-05-04 02:49:07,450 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Insulin glargine injected once daily will reach steady state levels in 2-4 days after the first dose. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:07,728 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Biotransformation' | Qrd txt :- 'Biotransformation' | Matched :- 'True'
2021-05-04 02:49:07,749 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20041' | currParentHeadId :- '20038.0' | prevParentHeadId :- '20038'
2021-05-04 02:49:07,938 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Elimination' | Qrd txt :- 'Elimination' | Matched :- 'True'
2021-05-04 02:49:07,959 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20042' | currParentHeadId :- '20038.0' | prevParentHeadId :- '20038'
2021-05-04 02:49:08,184 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'When given intravenously the elimination half-life of insulin glargine and human insulin were comparable. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:08,549 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Special populations' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:08,840 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In clinical studies, subgroup analyses based on age and gender did not indicate any difference in safety and efficacy in insulin glargine-treated patients compared to the entire study population.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:08,936 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:08,947 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20038'
2021-05-04 02:49:08,987 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:08,999 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20019' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20038'
2021-05-04 02:49:09,011 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:09,023 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20021' | currParentHeadId :- '20020.0' | prevParentHeadId :- '20038'
2021-05-04 02:49:09,057 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:09,071 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20028' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20038'
2021-05-04 02:49:09,089 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:09,103 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20031' | currParentHeadId :- '20030.0' | prevParentHeadId :- '20038'
2021-05-04 02:49:09,132 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'
2021-05-04 02:49:09,145 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Failed As Previous Heading Found is not matching | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20037' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20038'
2021-05-04 02:49:09,258 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:09,269 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Use in the paediatric population' | Matched :- 'False'
2021-05-04 02:49:09,600 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '5.3     Preclinical safety data' | Qrd txt :- '5.3 Preclinical safety data' | Matched :- 'True'
2021-05-04 02:49:09,612 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20045' | currParentHeadId :- '20032.0' | prevParentHeadId :- '20038'
2021-05-04 02:49:09,891 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:10,150 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.       PHARMACEUTICAL PARTICULARS' | Qrd txt :- '6. PHARMACEUTICAL PARTICULARS' | Matched :- 'True'
2021-05-04 02:49:10,161 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20047' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20045'
2021-05-04 02:49:10,485 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.1     List of excipients' | Qrd txt :- '6.1 List of excipients' | Matched :- 'True'
2021-05-04 02:49:10,494 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20048' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20047'
2021-05-04 02:49:12,676 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.2     Incompatibilities' | Qrd txt :- '6.2 Incompatibilities' | Matched :- 'True'
2021-05-04 02:49:12,687 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20049' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20048'
2021-05-04 02:49:12,902 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'This medicinal product must not be mixed with other medicinal products. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:12,922 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'This medicinal product must not be mixed with other medicinal products. ' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:13,350 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.3     Shelf life' | Qrd txt :- '6.3 Shelf life' | Matched :- 'True'
2021-05-04 02:49:13,363 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20050' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20049'
2021-05-04 02:49:14,166 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The medicinal product may be stored for a maximum of 28 days up to 30°C and away from direct heat or direct light. Pens in use must not be stored in the refrigerator. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:14,342 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The pen cap must be put back on the pen after each injection in order to protect from light.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:14,750 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.4     Special precautions for storage' | Qrd txt :- '6.4 Special precautions for storage' | Matched :- 'True'
2021-05-04 02:49:14,760 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20051' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20050'
2021-05-04 02:49:16,148 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Keep the pre-filled pen in the outer carton in order to protect from light.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:16,614 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'For storage conditions after first opening of this medicinal product, see section 6.3.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:17,065 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.5     Nature and contents of container' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'True'
2021-05-04 02:49:17,076 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20052' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20051'
2021-05-04 02:49:17,542 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '3 mL solution in a cartridge (type 1 colourless glass) with a plunger (halobutyl rubber) and a disc seal (laminate of polyisoprene and halobutyl rubber) with aluminium seal. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:17,809 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The cartridge is sealed in a disposable pen injector. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:17,824 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The cartridge is sealed in a disposable pen injector. ' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:19,668 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.6     Special precautions for disposal and other handling' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:19,677 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '6.6     Special precautions for disposal and other handling' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'True'
2021-05-04 02:49:19,689 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20053' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20052'
2021-05-04 02:49:20,009 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR must not be mixed with any other insulin or medicinal products or diluted. Mixing or diluting can change its time/action profile and mixing can cause precipitation.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:20,394 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR must not be mixed with any other insulin or diluted. Mixing or diluting can change its time/action profile and mixing can cause precipitation.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:20,694 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Empty pens must never be reused and must be properly discarded. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:21,026 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'To prevent the possible transmission of disease, each pen must be used by one patient only. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:21,060 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'To prevent the possible transmission of disease, each pen must be used by one patient only. ' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:21,410 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Insulin label must always be checked before each injection to avoid medication errors between insulin glargine and other insulins (see section 4.4).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:21,608 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'The patient should be advised to read the instructions for use included in the package leaflet carefully before using ABASAGLAR solution for injection in pre‑filled pen.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:22,201 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '7.       MARKETING AUTHORISATION HOLDER' | Qrd txt :- '7. MARKETING AUTHORISATION HOLDER' | Matched :- 'True'
2021-05-04 02:49:22,213 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20055' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20053'
2021-05-04 02:49:22,987 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '8.       MARKETING AUTHORISATION NUMBER(S)' | Qrd txt :- '7. MARKETING AUTHORISATION HOLDER' | Matched :- 'False'
2021-05-04 02:49:22,988 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '8.       MARKETING AUTHORISATION NUMBER(S)' | Qrd txt :- '8. MARKETING AUTHORISATION NUMBER(S)' | Matched :- 'True'
2021-05-04 02:49:22,999 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20056' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20055'
2021-05-04 02:49:24,753 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION' | Qrd txt :- '9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION' | Matched :- 'True'
2021-05-04 02:49:24,763 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20057' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20056'
2021-05-04 02:49:26,004 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '10.     DATE OF REVISION OF THE TEXT' | Qrd txt :- '10. DATE OF REVISION OF THE TEXT' | Matched :- 'True'
2021-05-04 02:49:26,014 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20058' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20057'
2021-05-04 02:49:26,303 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:48,595 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Starting Heading Extraction | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json
2021-05-04 02:49:48,595 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Starting Heading Extraction | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json
2021-05-04 02:49:48,876 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Started Extracting Heading | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json
2021-05-04 02:49:48,876 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Started Extracting Heading | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json
2021-05-04 02:49:49,128 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Qrd txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Matched :- 'True'
2021-05-04 02:49:49,128 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Qrd txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Matched :- 'True'
2021-05-04 02:49:49,136 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed As This The First Heading | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20001' | currParentHeadId :- 'nan' | prevParentHeadId :- ''
2021-05-04 02:49:49,136 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed As This The First Heading | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20001' | currParentHeadId :- 'nan' | prevParentHeadId :- ''
2021-05-04 02:49:49,180 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '1.       NAME OF THE MEDICINAL PRODUCT' | Qrd txt :- '1. NAME OF THE MEDICINAL PRODUCT' | Matched :- 'True'
2021-05-04 02:49:49,180 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '1.       NAME OF THE MEDICINAL PRODUCT' | Qrd txt :- '1. NAME OF THE MEDICINAL PRODUCT' | Matched :- 'True'
2021-05-04 02:49:49,193 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'
2021-05-04 02:49:49,193 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'
2021-05-04 02:49:49,197 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'
2021-05-04 02:49:49,197 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'
2021-05-04 02:49:49,792 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '2.       QUALITATIVE AND QUANTITATIVE COMPOSITION' | Qrd txt :- '2. QUALITATIVE AND QUANTITATIVE COMPOSITION' | Matched :- 'True'
2021-05-04 02:49:49,792 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '2.       QUALITATIVE AND QUANTITATIVE COMPOSITION' | Qrd txt :- '2. QUALITATIVE AND QUANTITATIVE COMPOSITION' | Matched :- 'True'
2021-05-04 02:49:49,805 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20004' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20003'
2021-05-04 02:49:49,805 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20004' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20003'
2021-05-04 02:49:50,535 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Each cartridge contains 3 mL of solution for injection, equivalent to 300 units. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:50,535 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Each cartridge contains 3 mL of solution for injection, equivalent to 300 units. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:51,335 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '3.       PHARMACEUTICAL FORM' | Qrd txt :- '3. PHARMACEUTICAL FORM' | Matched :- 'True'
2021-05-04 02:49:51,335 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '3.       PHARMACEUTICAL FORM' | Qrd txt :- '3. PHARMACEUTICAL FORM' | Matched :- 'True'
2021-05-04 02:49:51,351 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'
2021-05-04 02:49:51,351 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'
2021-05-04 02:49:51,351 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'
2021-05-04 02:49:51,351 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'
2021-05-04 02:49:52,155 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.       CLINICAL PARTICULARS' | Qrd txt :- '4. CLINICAL PARTICULARS' | Matched :- 'True'
2021-05-04 02:49:52,155 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.       CLINICAL PARTICULARS' | Qrd txt :- '4. CLINICAL PARTICULARS' | Matched :- 'True'
2021-05-04 02:49:52,155 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20009' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20008'
2021-05-04 02:49:52,155 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20009' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20008'
2021-05-04 02:49:52,252 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.1     Therapeutic indications' | Qrd txt :- '4.1 Therapeutic indications' | Matched :- 'True'
2021-05-04 02:49:52,252 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.1     Therapeutic indications' | Qrd txt :- '4.1 Therapeutic indications' | Matched :- 'True'
2021-05-04 02:49:52,267 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20010' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20009'
2021-05-04 02:49:52,267 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20010' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20009'
2021-05-04 02:49:52,524 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:52,524 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:52,558 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:52,558 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:52,737 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.2     Posology and method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'True'
2021-05-04 02:49:52,737 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- '4.2     Posology and method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'True'
2021-05-04 02:49:52,753 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20011' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20010'
2021-05-04 02:49:52,753 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20011' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20010'
2021-05-04 02:49:52,799 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'
2021-05-04 02:49:52,799 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'
2021-05-04 02:49:52,799 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- 'Posology' | Matched :- 'True'
2021-05-04 02:49:52,799 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- 'Posology' | Matched :- 'True'
2021-05-04 02:49:52,822 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20012' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'
2021-05-04 02:49:52,822 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Validation Passed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | currHeadId :- '20012' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'
2021-05-04 02:49:53,000 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR contains insulin glargine, an insulin analogue and has a prolonged duration of action. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:53,000 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'ABASAGLAR contains insulin glargine, an insulin analogue and has a prolonged duration of action. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:54,138 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Special populations' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:54,138 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'Special populations' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'
2021-05-04 02:49:55,094 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In the elderly, progressive deterioration of renal function may lead to a steady decrease in insulin requirements.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:55,094 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In the elderly, progressive deterioration of renal function may lead to a steady decrease in insulin requirements.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:55,828 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
2021-05-04 02:49:55,828 : Heading Extraction Abasaglar-h-2835-en_SmPC.json : Match Failed | CAP |  en | 0 | Abasaglar-h-2835-en_SmPC.json | Doc txt :- 'In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'
